LLY compared with BNTC: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

BNTCBenitec Biopharma Inc.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

BNTCBenitec Biopharma Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

Q1 FY26±5.3%▲+9.80%×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

BNTC

0 of 4at or beyond implied

Reportimpliedrealized× implied

Sep 15 '26±33.9%▼−8.53%×0.25

Q3 FY26±46.8%▲+1.72%×0.04

= impliedLLY realized, solidBNTC realized, hatchedOne scale, both sides: full bar = 47%× = |realized| ÷ impliedSource: market data

Feb 12 '26

±42.4%

▼−2.66%

×0.06

Nov 17 '25±33.2%▲+2.81%×0.08

LLYELI Lilly & Co

1,365.81▲+0.08%

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

BNTCBenitec Biopharma Inc.

8.66▼−6.64%

Regular sessionNov 6 '26

Mkt cap$323.7MRevenue$7,000Q4 FY23Revenue—

Compare

Regular sessionNov 6 '26

LLYELI Lilly & Co

BNTCBenitec Biopharma Inc.

1,365.81▲+0.08%

Price

8.66▼−6.64%

$1.2T

Mkt cap

$323.7M

Q3 FY26$24.4B

Revenue

$7,000Q4 FY23

FY25$65.2B

Revenue

—

LLY1,365.81▲+0.08%vsBNTC8.66▼−6.64%Regular sessionNov 6 '26